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The influence of normothermic and hypothermic ardiopulmonary bypass on 
defibril lation energy requirements and transcardiac impedance is not weil charac- 
terized. However, this relationship is of clinical importance during automatic 
defibri l lator implantation done with concomitant cardiac surgery, and there is 
anecdotal information that criteria for successful implantation are harder to achieve 
after such operations. We studied the effect of controlled hypothermia on defibril- 
lation energy requirements and transcardiac impedance in a canine model of 
cardiopulmonary bypass in which 26 animals underwent right atr ial  and femoral 
arterial  cannulation, as weil as continuous hemodynamic and intramyocardial  
temperature monitoring. The defibril lation energy requirements were evaluated at 
60-minute intervals with an epicardial patch system, and transcardiac impedance 
was measured before and after the multiple inductions and terminations of 
ventricular fibril lation. In group 1 (n = 10) defibril lation energy requirements were 
evaluated immediately after initiation of cardiopulmonary b pass at 37 ° C (To), after 
gradual cooling to 28 ° C (Tl), and after rewarming to 37 ° C (T2). Group 2 (n = 16) 
comprised time controls that were identically instrumented and studied, but 
maintained at 37°C throughout. Percent successful defibril lation was plotted 
against delivered energy, and the raw data fit by logistic regression. The energy at 
which 50% of shocks were successful (E5o) was 3.23 - 0.89 joules at To, 5.12 _ 1.85 
joules at Tl, and 4.42 - 1.22 joules at T2 in group 1; this was not significantly 
different from the corresponding group 2 Eso values, which were 3.11 - 1.39 joules, 
4.95 _ 2.47 joules, and 5.59 - 3.18 joules, respectively. Both gronps demonstrated 
a significant increase in Eso during the first hour of cardiopulmonary b pass (mean 
increase from T O to T1 was 1.89 joules in group 1 and 1.84 joules in group 2, p < 
0.05). Transmyocardial  impedance fell progressively dnring the group 2 experiments 
from 73.6 -+ 12.9 t l  at the beginning of the T O shock series to 61.4 - 8.9 [ l  at the end 
of the T2 shock series. A similar reduction in transmyocardial  impedance was 
observed uring the course of all the group I experiments; however, at the beginning 
of the T1 shock series impedance was significantly elevated to 77.4 - 12.3 I l  (p < 
0.05 compared with group 2 and with end T O in group 1). There was no relationship 
between defibril lation energy requirements and transcardiac impedance; there was 
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also no correlation between either of these parameters and intramyocardial extra- 
cellular pH or left ventricular end-diastolic pressure. We conclude that defibrillation 
energy requirements ignificantly and persistently increase during the first hour of 
cardiopulmonary bypass and the etfect is temperature independent. Systemic 
hypothermia significantly and reversibly elevates transmyocardial impedance but 
multiple shocks reduce this effect at 28 ° C as they do at 37 ° C. (J TItORAC CARDIOVASC 
SURG 1995;109:981-8) 
T he placement of implantable cardioverter-defi- brillators (ICDs) requires determination of defi- 
brillation energy requirements (or defibrillation 
"threshold"; DFT) so that an adequate safety mar- 
gin for device efficacy can be demonstrated. 1' 2 At 
least 10% of ICD implants are done concomitantly 
with cardiac operations that require cardiopulmo- 
nary bypass (CPB) and anoxic arrest; DFT testing is 
routinely done after such an operation is substan- 
tially complete and CPB has been partially or com- 
pletely discontinued for only a few minutes. 3 
Anecdotal reports suggest hat ICD implantation 
during operations in which CPB is used may be 
complicated by high DFT measurements; whether 
this is an immediate consequence of global ischemia 
or related to the mechanical effects of the pump is 
unknown. No rigorous assessment of the effect, if 
any, of normothermic and hypothermic CPB on the 
energy requirements for defibrillation has been 
done. 
In a study designed to reflect clinical practice, we 
used a canine model of CPB to evaluate the influ- 
ence of hypothermic and normothermic CPB on 
defibrillation energy requirements and transmyocar- 
dial impedance to defibrillatory shocks. We used a 
validated scientific method in which multiple induc- 
tions of ventricular fibrillation are required to gen- 
erate dose-response curves of defibrillation efficacy. 
The effects of CPB on transmyocardial impedance 
were evaluated because of a reported relationship 
between impedance and DFT that remains contro- 
versial. 4-6 In addition, CPB itself has been reported 
to have an effect on tissue impedance by virtue of its 
influence on water content. 7 The experimental 
model used in this study is the first to permit 
accurate and stable control of myocardial tempera- 
tute in an intact canine preparation. It was also out 
objective to define the relationships between in- 
tramyocardial pH (a measurement of the adequacy 
of tissue perfusion), transmyocardial impedance, 
and defibrillation energy requirements. 
Methods 
Animal preparation. All experimentation conformed 
with the requirements of the American Physiologic Soci- 
ety and the Animal Care Subcommittee of the Institu- 
tional Review Board of the West Roxbury Veterans 
Administration Medical Center. Adult male mongrel dogs 
weighing 30 to 35 pounds were anesthetized with sodium 
thiamylal (20 mg/kg intravenously), paralyzed with succi- 
nylcholine (20 mg intravenously atthe induction of anes- 
thesia only), and maintained on a ventilator throughout 
the experiment. Further anesthesia was established with 
halothane as needed. Arterial and venous access and 
pressure monitoring were done with use of the carotid and 
jugular vessels. The heart was exposed via a left thoracot- 
omy and suspended in a pericardial cradle. A high-fidelity 
micromanometer (Konigsberg Instruments, Pasadena, 
Calif.) was placed in the left ventricular cavity for mea- 
surement of developed and end-diastolic pressure, as well 
as the first time derivative of left ventricular pressure. 
Extracellular myocardial pH and myocardial temperature 
were continuously monitored in the anterior wall of the 
left ventricle with the use of previously described tech- 
niques. 8-1° 
Defibrillating patches with a surface area of 14 cm 2 
(Cardiac Pacemakers, Inc., St. Paul, Minn.) were sutured 
to the epicardium over the lateral aspects of both right 
and left ventricles; these "small" clinical patches were 
chosen for their proportionally equal coverage of the 
epicardial surface of the canine heart compared with the 
coverage offered by the conventionally used "large" clin- 
ical patches for human implants. A closely spaced bipole 
was established with screw-in epicardial electrodes (Car- 
diac Pacemakers, Inc.) on the lateral wall of the left 
ventricle. These epicardial electrodes were used to deliver 
alternating current for the induction of ventricular fibril- 
lation. Hemodynamic data (arterial and left ventricular 
pressure and the first time derivative of left ventricular 
pressure) were recorded continuously on a multichannel 
physiologic recorder, as were temperature and pH values. 
The defibrillating leads were connected to an external 
defibrfllator (ECD-2, Cardiae Pacemakers, Inc.) that used 
a single-phase truncated exponential waveform of 60% tilt 
and variable pulse width, thus ensuring that selected and 
delivered energies were almost identical and unaffeeted by 
changes in transmyocardial mpedance. This clinical de- 
viee has reproducible energy delivery over the whole of its 
energy fange of 0.1 to 40 joules; after a single battery 
charge the ECD-2 external defibrillator is capable of 
delivering more than 200 40-joule shocks (Cardiac Pace- 
makers, Inc., personal communieation, 1992). 
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Table I. Effects of  duration of  CPB 
Hypotherrnic Normothermic 
To (37~ ¢) T~ (28°C) T2 (37~ C) To (37~ C) 7"1 (37~ C) T~ (37~ C) 
E»0 (joules) 3.23 -+ 0.89 5.12 _+ 1.85" 4.42 + 1.22" 3.11 -+ 1.39 4.95 _+ 2.47* 5.59 2 3.18" 
HR (beats/min) 131 -+ 13 93 -+ 20* 141 _+ 19 138 -+ 18 136 + 24 140 ± 24 
Impl (I~) 74.2 -+ 4.1 77.4 + 12.3" 62.7 +_ 6.5 73.6 -+ 12.9 71.7 _+ 10.9 64.3 _ 6.8 
Imp2 (12) 72.6 -4- 8.7 75.7 _+ 8.3* 61.4 _+ 9.6 73.9 + 12.4 67.6 +_ 7.6 61.4 ± 8.9 
pH1 7.48 + 0.20 7.27 _+ 0.15' 7.37 _+ 0.15 7.48 _+ 0.13 7.49 _+ 0.14 7.42 +__ 0.12 
pH 2 7.41 _+ 0.18 7.25 + 0.17" 7.29 _+ 0.12 7.49 -4- 0.14 7.44 _+ 0.13 7.40 + 0.11 
LVEDP (mm Hg) 1.9 -+ 2.1 11.8 _+ 9.4* 3.6 + 5.5 2.5 +- 1.7 2.6 -+ 2.1 4.4 _+ 4.2 
Note that pH measurements at 28 ° C are corrected for temperature assuming ApH/° C = -0.015. 33 HR denotes heart rate in beats per minute; Irnpl denotes 
transmyocardial impedance b fore defibrillation dose-response curve generation; Imp2 denotes impedance immediately after completion f multiple shocks 
for curve generation;pH1 andpH2 are defined in the manner ofImpl and Imp2 , respectively. To,T» and T z refer to measurements made during the first, 
second, and third hours, respectively, of CPB. 
*p < 0.05 compared with To. 
After instrumentation the animal was heparinized (400 
units/kg) and placed on full CPB by passage of right atrial 
(34F) and femoral arterial (16F) cannulas. A Sarns mem- 
brane oxygenator (Sarns Inc./3M, Ann Arbor, Mich.) with 
a centrifugal pump primed with 500 ml of Ringer's lactate 
solution formed the core of the CPB circuit and flow was 
maintained at2 to 2.5 L/min. No cardioplegia was admin- 
istered, and the heart was allowed to continue beating in 
the partially unloaded state. Values of arterial blood 
gases, hematocrit, and serum electrolytes including cal- 
cium and magnesium were periodically measured and 
corrected as necessary during the experiment. Arterial pH 
was maintained between 7.35 and 7.45 at all times. 
Experimental procedure. The defibrillation energy re- 
quirements were estimated in this study by the generation 
of dose-response curves from which the energy for 50% 
successful defibrillation (the E5o) was derived. 11-13 For 
each animal three dose-response curves of defibrillation 
efficacy were defined at three consistent time intervals: To, 
immediately after establishment of CPB at 37 ° C, Tl, 1 
hour after the beginning of the T o dose-response curve; 
and T2, 2 hours after the beginning of the To dose- 
response curve. In group 1 animals the T1 measurements 
were made after gradual cooling during a 20-minute 
period to 28 ° C, and the T2 data were generated after 
gradual rewarming to 37 ° C. The target temperature of
28°C for cooling in group 1 experiments was chosen 
because it was the lowest temperature consistent with 
stable heart rhythm and hemodynamics. Temperatures 
below 28°C are frequently associated with atrial and 
ventricular arrhythmias, which may be intractable. 14-16 
Group 2 animals acted as time controls: all dose-response 
curves were generated at 37 ° C. 
After stabilization at37 ° C, the transcardiac impedance 
was measured by delivery of a 2-joule shock during sinus 
rhythm17; the impedance was measured by the external 
defibrillator 50/xsec into the pulse. This measurement was 
repeated after multiple shocks necessary for generation of
the defibrillation efficacy data, and such measurements 
were duplicated at each time point. Ventricular fibrillation 
was induced by delivery of 2 seconds of alternating 
current, and, after a 10-second elay, a shock was deliv- 
ered to attempt defibrillation. The initial energy selected 
was 15 joules, with energies for subsequent episodes of 
ventricular fibrillation delivered in decrements hrough 
10, 8, 5, 4, 3, 2, and 1 joule until failure to defibrillate 
occurred. If the first shock of 15 joules failed to 
defibrillate, then initial shock energies for subsequent 
episodes of ventricular fibrillation were increased pro- 
gressively to 20, 25, 30, 35, and 40 joules. After the first 
failure to defibrillate, subsequent energies were ran- 
domly selected from that energy, as well as the two 
higher and two lower settings available on the defibril- 
lator, and multiple shocks at these energy settings were 
delivered to develop the dose-response curve. For each 
episode of ventricular fibrillation only the response to 
the initial shock was included in data analysis. After 
successful defibrillation, hemodynamic parameters and 
pH were allowed to return to baseline before reinduc- 
tion of ventricular fibrillation. There was a minimum 
2-minute delay between defibrillation and reinduction 
of ventricular fibrillation. 
Data analysis. For each experiment at each time 
interval a logistic curve was generated relating percent 
successful defibrillation to stored energy. With the use 
of nonlinear egression the best fit to the following 
function was derived: y = e~/(1 + e 9. The energy at 
which 50% of shocks successfully terminated ventricu- 
lar fibrillation (the Eso) was derived from these 
curves. 18 Because the animals used in this study were all 
of closely similar weight, and because there is no strong 
correlation between total body or excised heart weight 
and Eso, the defibrillation energy requirements were 
not normalized for weight. 19 Repeated-measures anal.- 
ysis of variance was done to determine whether E»o, 
transmyocardial impedance, or intramyocardial pH 
changed with time or temperature. Pairwise differences 
were tested using paired t tests when the overall F test 
rejected the null hypothesis (Fisher's least significant 
difference procedure). Equality of variance in the nor- 
mothermic and hypothermic groups was evaluated by 
pooling the log transformed Eso data for each anirnal 
and comparing variances by an F test. Linear regression 
was used to explore the relationship between Eso and 
transmyocardial impedance. All results are expressed as 
mean plus or minus the standard eviation. A p value 
<0.05 was considered significant for all analyses. 
9 8 4 Martin et aL 









Fig. 1. Sample family of dose-response curves derived 
from single hypothermic (group 1) experiment. Circles 
denote measurements made immediately after establish- 
ment of CPB; triangles and squares denote repeated 
dose-response measurements made after 1 and 2 hours of 






2 3 4 5 TO T1 T2 
Energy (J) Fig. 2. Graph showing defibrillation energy requirements 
(E»o) immediately after CPB is established (To), after 1 
hour (Tl), and after 2 hours (T2). Hatched bars denote 
hypothermic (group 1) experiments; open bars denote 
normothermic (group 2) experiments. 
Results 
Of 35 dogs surgically prepared for this experimen- 
tal protocol, nine became hemodynamically or met- 
abolically unstable (n = 7) or were unable to be 
cannulated for CPB (n = 2). Results for the remain- 
ing 26 animals are presented; there were 10 group 1 
(hypothermic) and 16 group 2 (normothermic) ex- 
periments reflecting increased wastage in the hypo- 
thermic cohort. Table I summarizes the effect of 
bypass duration on defibrillation energy require- 
ments (E»0), transmyocardial impedance, and in- 
tramyocardial pH in both groups. 
Defibrillation energy requirements. The logistic 
model used in the derivation of the defibrillation 
dose-response curves satisfactorily fitted the data 
derived from each individual animal and there was 
no difference in variance of the data between the 
two groups. A sample family of dose-response 
curves from a single experiment is shown graphically 
in Fig. 1, and the pooled data are summarized inFig. 
2. In both groups the Es0 immediately after estab- 
lishment of CPB (To) was comparable (3.23 joules 
and 3.11 joules, p = not signifieant). There was a 
significant inerease in E»0 in both groups after the 
first hour of CPB (Tx) to 5.12 joules in group 1 and 
4.95 joules in group 2 (p = 0.0001). However, there 
remained no difference between the groups indicat- 
ing no separate ffect of hypothermia on the energy 
requirement for defibrillation. This elevation in E»0 
was sustained after the second hour of CPB (Tl) 
at 4.42 joules in group 1 and 5.59 joules in group 2 
(p = not significant for both the between-group 
comparison and the within-group time effect). 
Transmyocardial impedance. Resistance to the 
current of a 2-joule shock measured across the 
defibrillating patches during sinus rhythm ranged 
from 40 ~ to 98 1~ throughout the experiment in 
both groups. Impedance, computed as a percentage 
of baseline value, was significantly lower after the 
multiple shocks necessary for the generation of a 
dose-response curve compared with the precurve 
measurement in each group at each time interval 
with the exception of the To data in group 2; this 
relative change in impedance from baseline is shown 
graphically in Fig. 3. Transmyocardial impedance 
increased significantly after cooling, rising from 
74.2 ~ at 37 ° C to 77.4 ~ at 28 ° C; after rewarming 
to 37 ° C impedance fell significantly to 62 l-l, which 
is not statistically different from the impedance of 
64 gl in the group 2 animals at the same time 
interval. This elevation in impedance at 28 ° C is in 
marked contrast o the changes in transmyocardial 
impedance observed in the group 2 experiments 
over the same time course but at a constant 37 ° C: in 
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Fig. 3. Graph of pooled impedance data expressed as 
percentage of impedance at beginning of To defibrillation 
dose-response curve generation plotted for beginning and 
end of each series of inductions of ventricular fibrillation. 
Closed circles denote bypothermic (group 1) experiments; 
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Fig. 4. Graph showing changes in extracellular intra- 
myocardial pH during 2 hours of CPB. Symbols are as in 
Fig. 2. 
these latter experiments he impedance fell progres- 
sively during the period of cardiopulmonary b pass 
as illustrated in Fig. 2. Linear regression analysis 
disclosed no relationship between defibrillation en- 
ergy requirements and the transmyocardial imped- 
ance (r = 0.06). 
Intramyoeardial plt. Extracellular intramyocar- 
dial acid-base balance remained stable throughout 
the experiments while the preparation was main- 
tained at 37 ° C. However, there was a significant 
acidosis at 28 ° C, even after we corrected for the 
effect of temperature on the measurement, with a 
fall in mean pH from 7.48 at baseline to 7.27 after 
cooling (Fig. 4). 20' 21 Mean pH at 37 ° C ranged from 
7.29 to 7.49 and no significant differences emerged 
when paired data from groups 1 and 2 were com- 
pared at similar time points provided the tempera- 
tute was 37 ° C. In addition, no changes were noted 
in paired pH values measured before and immedi- 
ately after the multiple shocks necessary for the 
generation of the defibrillation efficacy dose-re- 
sponse curves. 
Hemodynamic indices. Heart rate (mean 136 to 
140 beats/min) remained stable throughout the ex- 
periment when the temperature was kept constant 
at 37 ° C. However, heart rate fell significantly (from 
131 to 93 beats/min) in group 1 animals after they 
were cooled to 28 ° C during the second hour of CPB 
(Fig. 5). Left ventricular end-diastolic pressure 
(LVEDP) remained low in all normothermic exper- 
iments with no significant change over the 2 hours of 
CPB. However, in group 1 the mean LVEDP rose 
significantly from 2.5 mm Hg at 37 ° C to 11.8 mm 
Hg at 28 ° C; after rewarming the mean LVEDP in 
these preparations returned to 3.6 mm Hg as shown 
in Fig. 6. Despite the increase in both impedance 
and LVEDP at 28 ° C, there was no correlation 
between these parameters (r = 0.12). In addition, 
there was no relationship between intramyocardial 
pH and LVEDP (r = 0.07). 
Discussion 
This is the first study to describe the effects of 
noncardioplegic CPB on defibrillation energy re- 
quirements as measured by the dose-response 
method. We have shown that the Es0 increases 
significantly during the first hour of CPB and that 
hypothermia neither ameliorates nor exacerbates 
this effect. Our results differ from those of a study by 
Klein and co-workers 22 in which the investigators 
reported no effect of CPB on defibrillation energy 
requirements. Their study included 10 patients un- 
dergoing cardiac surgery who underwent DFT mea- 
surement with a combined transvenous/epicardial 
9 8 6 Martin et aL 
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Fig. 6. Graph showing changes in LVEDP during 2 hours Fig. 5. Graph showing changes in heart rate during 2 of CPB. Symbols are as in Fig. 2. 
hours of CPB. Symbols are as in Fig. 2. 
system immediately after cannulation and 10 min- 
utes after the establishment of full-flow bypass. In 
Klein's study DFT was measured with a method the 
reliability of which is now questioned by the same 
investigators. 18 In contrast, our experimental proto- 
col was designed to parallel clinical practice by 
allowing a longer duration of bypass and serial 
defibrillation threshold testing with use of a valid 
method. 
The progressive reduction in transmyocardial m- 
pedance observed in our study during 2 hours of 
normothermic CPB confirms earlier observations on 
the effect of multiple shocks in which transthoracic 
defibrillation was usedY -25 After the generation of 
the defibrillation dose-response curve at 28°C the 
impedance in our study remained elevated albeit to 
a lesser degree, demonstrating that this multiple 
shock effect also occurs under hypothermic condi- 
tions. 
The statistically significant increase in transmyo- 
cardial impedance both before and after multiple 
shocks at 28°C is an important finding that may 
have clinical relevance. The mean impedance in- 
crease at 28 ° C in our study was only 4%, bnt 50% of 
the animals demonstrated an increase of more than 
20%. Elevations in impedance proportionally re- 
duce energy delivery to myocardium when fixed 
pulse width defibrillators are used: therefore this 
phenomenon may be at least partly responsible for 
impaired resuscitation i hypothermia and in other 
patients after prolonged ventricular fibrillation. 26 
The relative degree of intramyocardial cidosis 
(manifested by a significant reduction in tempera- 
ture-corrected pH) observed at 28°C may reflect 
ischemia, as is usually imputed from such values 
recorded clinically. 1°' 27, 28 However, it may be that 
the low pH reflected reduced washout rather than 
increased production of H ÷ ions and that therefore 
there was no true intracellular acidosis. It is note- 
worthy that no animals in our study developed 
spontaneous ventricular fibrillation during cooling 
and that this degree of "acidosis" manifestly had no 
effect on defibrillation energy requirements. Our 
findings with regard to intramyocardial pH contrast 
with those of earlier clinical studies of acid-base 
status during hypothermic CPB, 29'3° particularly 
with the work of Swain, White, and Peters. 31 They 
reported that cardiac electrical stability (as evi- 
denced by the ventricular fibrillation threshold) was 
improved by maintenance of alkaline pH (7.58) 
during hypothermia, thereby reproducing the meta- 
bolic adjustments made by ectothermic species. Our 
findings also differ from those of Echt, Cato, and 
Coxe, al who found that the elevating effect of lido- 
caine on defibrillation threshold was pH-dependent 
and could be enhanced and reversed by acidosis and 
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alkalosis, respectively. This variance in our data 
from those of previously published reports may be 
explained by the fact that we directly measured 
extracellular myocardial pH in contrast to most 
work, which has relied solely on arterial blood gas 
data, an insensitive index of myocardial acidosis. 31 
The elevation in LVEDP observed at 28°C re- 
flects reduced myocardial compliance, possibly be- 
cause of the edema associated with hypothermia; 
because of previous work from our laboratory elu- 
cidating the time course of ischemic damage under 
hypothermic conditions we do not believe the ele- 
vation in LVEDP is caused by ischemia. 2s Although 
acute increases in ventricular volume and pressure 
have been shown in other models to be arrhythmo- 
genic, 32 it is noteworthy that in our study these 
significant elevations in LVEDP were not associated 
with increased spontaneous arrhythmia or increased 
energy requirements for defibrillation. 
This study is limited by the inability to achieve 
"true" normothermia during CPB because of the 
open-chest nature of the model. Initial myocardial 
temperatures after the establishment of CPB were 
typically 35 ° C and all preparations were warmed to 
37°C before initiation of ventricular fibrillation; 
however, the normal canine core temperature is
39°C and we were unable to achieve this for the 
normothermic testing protocol because of heat loss 
through the wound despite use of a radiant heat 
source above the operating fiel& Other potential 
limitations of this study relate to the true electro- 
physiologic omparability of groups 1 and 2 during 
the T1 testing period (at 28 ° C in group 1 and 37 ° C 
in group 2). The temperature difference between 
preparations in the two groups was responsible for 
the difference in heart rates and the significant 
bradycardia in the hypothermic group may account 
for the elevation in transmyocardial impedance. 
Because the ionic mechanism underlying the dy- 
namics of myocardial electrical impedance is un- 
known, it remains unclear whether heart rate or 
temperature (alone or in combination) is responsi- 
ble for this observation. Atrial pacing in the group 1 
preparations during the T1 testing (done to maintain 
constancy of heart rate) might have clarified this 
question, but would have deleteriously affected myo- 
cardial metabolism and the hemodynamic stability 
of the experimental preparation. 
In conclusion, our data suggest hat CPB has 
electrophysiologic effects that may have clinical im- 
portance. The significant elevation in defibrillation 
energy requirements observed in this study during 
both normothermic and hypothermic CPB is not 
related to changes in hemodynamic or acid-base 
status. Marked elevations in defibrillation threshold 
that may be observed clinically after CPB may 
therefore be the consequences of this procedure. 
Our study was done with normal canine hearts; 
pathologically-enlarged, infarcted, or hypertrophic 
human hearts (the usual substrate in which ICD 
implantation is done) would be expected to exhibit 
more dramatic elevations in DFr  after CPB. Fur- 
ther work is needed to define the duration of this 
effect after termination of bypass. 
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